A multipronged immune attack that includes CAR-T treatments may be needed to fight glioblastoma, Penn scientists suggest.
An international group of scientists is turning to a surprising ally in the quest to develop an HIV vaccine: the cow.
With pressures to fast-track clinical development, the pharmaceutical industry recognizes the value of improving internal clinical data management processes.…
Feinstein Institute-led researchers used an Alzheimer’s drug to reduce inflammation in people with metabolic syndrome.
Targeting a cell process that promotes protein clumping could lead to new drugs for ALS.
This past week ushered in new discoveries in flu prevention, pancreatic cancer and HIV.
Penn scientists discovered three genetic variants that may help the immune system fight Alzheimer’s—and that may be targetable with drugs.
A pair of experimental vaccines protected mouse fetuses from brain defects caused by Zika infection.
Anti-CRISPR proteins may be the key to preventing harmful side effects from off-target editing.
M.D. Anderson Cancer Center researchers are developing a CAR-T alternative derived from umbilical cord blood.
Researchers at Washington University have discovered a new way to shield fetuses from Zika using a common and inexpensive malaria drug.